Clinical Studies
Media Center
Glossary
Footnotes
Case Studies
Media Center
Print | E-mail

Theragenics Corporation® welcomes media inquiries about TheraSeed® treatment. Please contact Lisa Rassel at Theragenics® at 770-271-0233 for more information. In addition, please visit our company Web site at www.theragenics.com for additional press releases, the annual report and other pertinent information.

News Releases
Theragenics Corporation® Bucks Traditional Healthcare Marketing and Returns to Professional Bull Riding to Promote Prostate Cancer Treatment Awareness Campaign
Medicare Legislation Extends Safeguards for Fair Reimbursement of Brachytherapy Seeds
15-Year Study of More Than 5,000 Patients Reveals Key Factors in Predicting Outcomes for Prostate Cancer Recurrence Following Permanent Prostate Brachytherapy
New Peer-Reviewed Study Demonstrates Brachytherapy With Palladium-103 Is Better Than Or Equal To Prostatectomy For Treating Prostate Cancer
Calling All Cowboys: Theragenics Corporation® Taps Professional Bull Riders to Educate Millions of Fans
U.S. Senate Adopts Resolution Encouraging Doctors to Inform Prostate Cancer Patients about All Proven Treatments
U.S. House of Representatives Adopts Resolution Encouraging Doctors to Inform Prostate Cancer Patients about All Proven Treatments
Medicare Reform Act Reflects Fair Reimbursement for Brachytherapy Seeds for Prostate Cancer
Largest-Ever Patient Study of Prostate Brachytherapy Reveals Long-Term Success Rates for Cancer Treatment; 1,129 Patients Treated With Palladium-103 `Seeds' In 12-Year Research

Articles
Can minimally-invasive radiation therapy cure prostate cancer? Research indicates that may be the case.
Professional bull rider Owen Washburn films TV commercial about TheraSeed® treatment to "let people know that treatment options do exist."
Men, Healthcare and Prostate Cancer: Learn about men’s psychological defense structure and why “productive worry” is helpful.